Skip to content

Efficacy and Safety Study of Individualized and Standardized Acupuncture Treatment for Knee osteoarthritis

Efficacy and Safety Study of Individualized and Standardized Acupuncture Treatment for Knee osteoarthritis

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0000385
Enrollment
250
Registered
2012-03-19
Start date
2011-04-05
Completion date
Unknown
Last updated
2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Individualized electro-acupuncture Standard electro-acupuncture Sham acupuncture Waiting list except waiting list, Individualized electro-acupuncture group, Standard electro-acupunct

Sponsors

Dongguk University Ilsan Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: At least 20 years of age, but below 80 years of age 1. Knee pain from OA in one or both knees in the last 3 months or more 2. Presence of knee OA diagnosed by an orthopedist based on American College of Rheumatology classification criteria 3. Knee pain from OA in one or both knees rated > 4 cm on a 10 cm Visual Analog Scale (VAS) 4. An understanding of the objectives and methods of the clinical trial, and willingness in completing the consent form. 5. Those who are reliable and willing to cooperate in this test, and obey the restrictions for the next 6 months

Exclusion criteria

Exclusion criteria: 1. Trauma to or surgery on the knee(s) within 6 months prior to enrollment, causing pain or functional problems 2. A history of prolotherapy, injection of hyaluronic acid or cortisone within the last 3 months 3. A physical or laboratory finding indicating infection, presence of an autoimmune disease, or inflammatory arthritis 4. Serious organic disease, and severe dysfunction due to the medical illness (e.g. Arrhythmia, Angina pectoris, Stroke, Asthma, etc. 5. More severe pain in regions other than the knee joint. 6. Pregnant 7. When researchers evaluate that it is not appropriate to participate in this clinical test

Design outcomes

Primary

MeasureTime frame
WOMAC (Westren Ontario and McMaster Universities) Scale change

Secondary

MeasureTime frame
WOMAC pain;100mm Pain VAS on walking;Investigator global assessment(IGA);Patient global assessment(PGA);6 Minute walk test ;adverse events

Countries

Korea, Republic of

Contacts

Public ContactEun Jung Kim

Dongguk University Ilsan Hospital

hanijjung@naver.com+82-31-961-9116

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026